HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Ingenic Semiconductor (PHIP Updates) - Some Points Worth the Attention

Ingenic Semiconductor (300223 CH | 3223 HK): Dual Primary Listing (A+H) Initiation

Pre-IPO Mech-Mind Robotics Technologies (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Junlebao Dairy Group - The Strength and the Concerns

Pre-IPO Zenshine Pharmaceuticals (Nanjing) Group - The Core Product Faces Significant Challenges

Pre-IPO BioRay Biopharmaceutical - The Core Business Is Facing Challenges

Equity Capital Markets

Suzhou Dongshan Precision A / Equity Capital Markets

<ul>
<li>Dongshan's core competitiveness lies in its technological R&amp;D barriers. Dongshan has the ability to provide integrated comprehensive solutions, making it one of the few all-round suppliers among new energy customers.</li>
<li>Affected by the price reduction of old models from major customers in 2024, Dongshan’s profit was under pressure. The improvement in 26Q1 results indicates that performance turning point has occurred. </li>
<li>There is usually a 20%-40% A/H discount, but Hong Kong stock market shows high recognition for high-growth technology-based manufacturing enterprises. Therefore, we expect an A/H discount of 20-30% for Dongshan. </li>
</ul>


Dongshan's core competitiveness lies in its technological R&amp;D barriers. Dongshan has the ability to provide integrated comprehensive solutions, making it one of the few all-round suppliers among new energy customers.
Affected by the price reduction of old models from major customers in 2024, Dongshan’s profit was under pressure. The improvement in 26Q1 results indicates that performance turning point has occurred. 
There is usually a 20%-40% A/H discount, but Hong Kong stock market shows high recognition for high-growth technology-based manufacturing enterprises. Therefore, we expect an A/H discount of 20-30% for Dongshan. 


Pre-IPO Suzhou Dongshan Precision Manufacturing (A/H Listing) - The Turning Point Has Occurred